**New infection warning as ’39 million people could die’ – Wales Online**
A recent report published in The Lancet has flagged a concerning estimate that over 39 million people could succumb to antibiotic-resistant infections by 2050. The study underscores the urgency for global action to safeguard individuals worldwide from the looming threat posed by drug resistance in combating infections.
The data reveals that over one million individuals lost their lives annually due to drug-resistant infections between 1990 and 2021. While there was a 50% decline in antimicrobial resistance (AMR) deaths among children under five years old during this period, there was an alarming 80% surge in deaths among those aged 70 and above.
The findings stress the necessity for implementing comprehensive measures such as infection prevention, vaccination, prudent use of antibiotics, and expedited research into novel antibiotics to mitigate the projected rise in AMR fatalities by 2050. The study forecasts a potential 1.91 million deaths directly attributable to AMR by 2050, marking a nearly 70% surge per year compared to 2022.
AMR emerges when pathogens evolve to resist treatments, rendering medications ineffective. The study authors emphasize the critical need for novel strategies to combat infections effectively, including vaccine development, improved healthcare, enhanced antibiotic accessibility, and guidelines for their optimal usage.
Experts caution that without immediate intervention, humanity faces a perilous escalation in resistance against fungal diseases. Scientists are exploring the potential role of monoclonal antibodies, manufactured through genetic engineering, in combating AMR. These antibodies have shown promise in preventing infections caused by certain bacteria, marking a step towards developing more potent treatments.
The World Health Organisation has classified AMR as a top global public health threat. The new research underscores the importance of vigilant action to curb AMR-related deaths and calls for a collaborative, proactive approach to address this pressing health crisis.